Found: 13
Select item for more details and to access through your institution.
Cost comparison of adverse event management among breast and ovarian cancer patients treated with poly (ADP-ribose) polymerase inhibitors: analysis based on phase 3 clinical trials.
- Published in:
- Journal of Market Access & Health Policy, 2022, v. 10, n. 1, p. 1, doi. 10.1080/20016689.2022.2078474
- By:
- Publication type:
- Article
A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer.
- Published in:
- PharmacoEconomics, 2020, v. 38, n. 11, p. 1201, doi. 10.1007/s40273-020-00949-9
- By:
- Publication type:
- Article
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit.
- Published in:
- Applied Health Economics & Health Policy, 2024, v. 22, n. 5, p. 619, doi. 10.1007/s40258-024-00884-2
- By:
- Publication type:
- Article
Cost Effectiveness of CT Colonography for UK NHS Colorectal Cancer Screening of Asymptomatic Adults Aged 60-69 Years.
- Published in:
- Applied Health Economics & Health Policy, 2010, v. 8, n. 3, p. 141, doi. 10.2165/11535650-000000000-00000
- By:
- Publication type:
- Article
A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS).
- Published in:
- Acta Ophthalmologica (1755375X), 2018, v. 96, n. 8, p. e942, doi. 10.1111/aos.13771
- By:
- Publication type:
- Article
Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/ vitamin K antagonist.
- Published in:
- Thrombosis Journal, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12959-015-0051-3
- By:
- Publication type:
- Article
An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic model.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 587, doi. 10.1186/1471-2407-14-364
- By:
- Publication type:
- Article
Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic model.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-364
- By:
- Publication type:
- Article
Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic model.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME).
- Published in:
- BMC Ophthalmology, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12886-015-0035-x
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Biomarker Testing to Guide First-Line PARP Inhibitor Maintenance for Patients with Advanced Ovarian Cancer After Response to First-Line Platinum Chemotherapy in the USA.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 4, p. 531, doi. 10.1007/s11523-023-00966-6
- By:
- Publication type:
- Article
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC).
- Published in:
- Targeted Oncology, 2021, v. 16, n. 5, p. 613, doi. 10.1007/s11523-021-00837-y
- By:
- Publication type:
- Article